Tandem Diabetes Care Inc (TNDM)
Solvency ratios
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt-to-assets ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Debt-to-capital ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Debt-to-equity ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial leverage ratio | 3.68 | 4.03 | 4.01 | 3.87 | 3.04 | 2.99 | 2.88 | 2.82 | 2.39 | 2.48 | 2.31 | 2.32 | 2.09 | 2.18 | 2.30 | 2.41 | 1.96 | 2.06 | 2.30 | 1.66 |
Tandem Diabetes Care Inc has consistently maintained a very strong solvency position, as indicated by its solvency ratios. The Debt-to-assets ratio, Debt-to-capital ratio, and Debt-to-equity ratio have all been at 0.00 for the past several periods, reflecting that the company has no debt in relation to its total assets, capital, or equity.
The Financial leverage ratio, which measures the extent to which a company is using debt to finance its operations, has shown an increasing trend over the periods analyzed. This ratio has risen from 1.66 on March 31, 2020, to 3.68 on December 31, 2024. While this increase suggests that the company's reliance on debt has been rising over time, it is important to note that the ratio is still relatively low, indicating a conservative financial structure.
Overall, Tandem Diabetes Care Inc's solvency ratios demonstrate a financially robust position with minimal debt levels and a conservative approach to financing its operations.
Coverage ratios
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Interest coverage | -12.96 | -19.31 | -13.48 | -14.35 | -22.68 | -21.34 | -39.90 | -39.78 | -20.19 | -12.47 | -1.31 | 2.20 | 4.64 | 3.63 | 1.41 | -1.15 | -2.03 | -5.04 | -10.32 | -21.20 |
Interest coverage ratio indicates a company's ability to meet its interest obligations on outstanding debt. A higher ratio is generally favorable as it suggests the company is generating sufficient earnings to cover its interest expenses.
For Tandem Diabetes Care Inc, the interest coverage ratio has shown a declining trend over the past few quarters from negative values, indicating that the company's operating income was not enough to cover its interest payments. However, starting from the June 30, 2021 quarter, the interest coverage ratio turned positive, indicating an improvement in the company's ability to cover its interest expenses.
The trend continued to be positive until March 31, 2023, where the interest coverage ratio plummeted again to negative values, suggesting a potential strain on the company's ability to meet its interest obligations. Despite a slight recovery in the subsequent quarters, the ratio remained negative, indicating ongoing challenges in generating sufficient earnings to cover interest costs.
Overall, Tandem Diabetes Care Inc has shown fluctuations in its interest coverage ratio, highlighting the importance of closely monitoring the company's financial performance and taking necessary actions to improve its ability to meet interest payments.